DE69108392T2 - Zusammensetzung zur aktivierung der makrophagen. - Google Patents
Zusammensetzung zur aktivierung der makrophagen.Info
- Publication number
- DE69108392T2 DE69108392T2 DE69108392T DE69108392T DE69108392T2 DE 69108392 T2 DE69108392 T2 DE 69108392T2 DE 69108392 T DE69108392 T DE 69108392T DE 69108392 T DE69108392 T DE 69108392T DE 69108392 T2 DE69108392 T2 DE 69108392T2
- Authority
- DE
- Germany
- Prior art keywords
- compounds
- activating
- macrophages
- composition
- phosphatidyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
- C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/509,338 US5416070A (en) | 1988-07-08 | 1990-04-13 | Composition for macrophage activation |
PCT/US1991/001664 WO1991016347A1 (en) | 1990-04-13 | 1991-03-12 | Composition for macrophage activation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69108392D1 DE69108392D1 (de) | 1995-04-27 |
DE69108392T2 true DE69108392T2 (de) | 1995-08-03 |
Family
ID=24026246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69108392T Expired - Fee Related DE69108392T2 (de) | 1990-04-13 | 1991-03-12 | Zusammensetzung zur aktivierung der makrophagen. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5416070A (de) |
EP (1) | EP0527803B1 (de) |
JP (1) | JPH05506657A (de) |
AT (1) | ATE120207T1 (de) |
CA (1) | CA2080002A1 (de) |
DE (1) | DE69108392T2 (de) |
DK (1) | DK0527803T3 (de) |
ES (1) | ES2071995T3 (de) |
IE (1) | IE74195B1 (de) |
WO (1) | WO1991016347A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292524A (en) * | 1991-09-06 | 1994-03-08 | California Institute Of Technology | Blood platelet loaded with diagnostic or therapeutic-containing liposome or reconstituted Sendai virus |
IT1252160B (it) * | 1991-12-03 | 1995-06-05 | Giuseppe Fichera | Composizioni farmaceutiche contenenti il peptidoglicano del lactobacillus casei |
FR2694559B1 (fr) * | 1992-08-06 | 1994-10-28 | Atta | Nouveaux dérivés amphiphiles d'aminoacides ou de peptides, leur procédé de préparation et leur utilisation dans des préparations à usage biomédical. |
US6083513A (en) * | 1993-11-16 | 2000-07-04 | Gerbu Biotechnik Gmbh | Method for increasing the yield of antibodies in the techniques of immunology |
US6218166B1 (en) | 1994-12-09 | 2001-04-17 | John Wayne Cancer Institute | Adjuvant incorporation into antigen carrying cells: compositions and methods |
AU4057300A (en) | 1999-03-30 | 2000-10-16 | Board Of Regents, The University Of Texas System | Compositions and methods for modifying toxic effects of proteinacious compounds |
US6353032B1 (en) * | 1999-11-09 | 2002-03-05 | Alcon Universal Ltd. | Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use |
US20040002068A1 (en) | 2000-03-01 | 2004-01-01 | Corixa Corporation | Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
US6544564B1 (en) * | 2001-11-27 | 2003-04-08 | Michael Donald Farley | Cytotoxic pharmaceutical composition |
JP2013043885A (ja) * | 2011-08-26 | 2013-03-04 | Kansai Bunri Sogo Gakuen | デヒドロアミノ酸含有グリセロール誘導体 |
MX2018010586A (es) | 2016-03-02 | 2019-03-28 | Univ Texas | Nanovacuna de activacion de "sting" para inmunoterapia. |
US11376320B2 (en) | 2020-03-05 | 2022-07-05 | Iowa State University Research Foundation, Inc. | Immunogenic and vaccine compositions against SARS-CoV-2 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3976544A (en) * | 1973-06-19 | 1976-08-24 | The Agence Nationale De Valorisation De Le Recherche | Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction |
US4186194A (en) * | 1973-10-23 | 1980-01-29 | Agence Nationale De Valorisation De La Recherche (Anvar) | Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents |
FR2268531B1 (de) * | 1974-04-25 | 1978-07-21 | Anvar | |
US4172125A (en) * | 1974-10-22 | 1979-10-23 | Agence Nationale De Valorisation De La Recherche (Anvar) | Oil-free adjuvant compositions containing N-acetyl-muramyl-L-alanyl-D-glutamic acid and method of use |
US4370265A (en) * | 1974-10-22 | 1983-01-25 | Agence Nationale De Valorisation | Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents |
IL48325A (en) * | 1974-10-22 | 1979-05-31 | Anvar | Immunological-free adjuvant compositions containing n-acetyl muramyl-alanyl-d-isoglutamine or n-acetyl-muramyl-l-alanyl-d-glutamicn acid |
FR2313078A1 (fr) * | 1975-02-07 | 1976-12-31 | Anvar | Composition a base d'huile vegetale metabolisable et d'eau, utilisable notamment pour la constitution de preparations adjuvantes, ces preparations adjuvantes et leur procede d'obtention |
FR2321896A1 (fr) * | 1975-08-29 | 1977-03-25 | Anvar | Agents adjuvants immunologiques actifs en solution aqueuse |
PH14773A (en) * | 1976-01-01 | 1981-12-09 | Kureha Chemical Ind Co Ltd | Protein-bound polysaccharides |
FR2369292A1 (fr) * | 1976-11-02 | 1978-05-26 | Anvar | Agents adjuvants immunit |
US4153684A (en) * | 1976-03-10 | 1979-05-08 | Agence Nationale De Valorisation De La Recherche (Anvar) | Immunizing and anti-infectious adjuvant agents constituted by N-acetyl-muramyl-L-alanyl-D-glutamic acid derivatives |
GB1563561A (en) * | 1976-06-23 | 1980-03-26 | Daiichi Seiyaku Co | Muramyldipeptide derivatives and process for the preparation thereof |
FR2368282A1 (fr) * | 1976-10-22 | 1978-05-19 | Anvar | Adjuvant immunologique constitue par le p-amino-phenyl de n-acetyl-muramyl-l-alanyl-d-isoglutamine |
SU727647A1 (ru) * | 1977-11-02 | 1980-04-15 | Институт биоорганической химии им.М.М.Шемякина | Гликопептиды,обладающие противоопухолевой активностью и способ их получени |
US4397844A (en) * | 1978-02-24 | 1983-08-09 | Ciba-Geigy Corporation | Antigen derivatives and processes for their preparation |
FR2442241A2 (fr) * | 1978-03-20 | 1980-06-20 | Anvar | Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes |
FR2428050A1 (fr) * | 1978-06-05 | 1980-01-04 | Anvar | Oligomeres de composes du type muramyl-peptide et medicaments les contenant |
JPS5543030A (en) * | 1978-09-21 | 1980-03-26 | Dai Ichi Seiyaku Co Ltd | Prophylactic and remedy for microbial infection disease |
FR2446292A1 (fr) * | 1979-01-12 | 1980-08-08 | Anvar | Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant |
US4256735A (en) * | 1979-01-29 | 1981-03-17 | Merck & Co., Inc. | Immunologically active dipeptidyl saccharides and methods of preparation |
FR2449697A1 (fr) * | 1979-02-20 | 1980-09-19 | Anvar | Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant |
US4391800A (en) * | 1979-04-27 | 1983-07-05 | Merck & Co., Inc. | Immunologically active peptidyl disaccharides and methods of preparation |
JPS5618996A (en) * | 1979-06-21 | 1981-02-23 | Dai Ichi Seiyaku Co Ltd | Muramyldipeptide derivative |
FI75578C (fi) * | 1979-07-25 | 1988-07-11 | Ciba Geigy Ag | Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider. |
JPS5943929B2 (ja) * | 1979-08-13 | 1984-10-25 | サッポロビール株式会社 | 多糖体rbs物質,その製法およびそれを有効成分とする抗腫瘍性剤 |
US4357322A (en) * | 1980-07-29 | 1982-11-02 | Syntex (U.S.A.) Inc. | Method of preventing, reducing or inhibiting inflammation |
JPS58126797A (ja) * | 1982-01-22 | 1983-07-28 | Dainippon Pharmaceut Co Ltd | ジサツカライドトリペプチド及びジサツカライドテトラペプチドの製法 |
JPS58198496A (ja) * | 1982-05-14 | 1983-11-18 | Dainippon Pharmaceut Co Ltd | グルコサミニルムラミルペプチド誘導体 |
US4435386A (en) * | 1982-05-26 | 1984-03-06 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
US4505900A (en) * | 1982-05-26 | 1985-03-19 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
US4436728A (en) * | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
US4436727A (en) * | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
US4505899A (en) * | 1982-05-26 | 1985-03-19 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
US4522811A (en) * | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US4770874A (en) * | 1983-08-22 | 1988-09-13 | Syntex (U.S.A.) Inc. | Polyoxypropylene-polyoxyethylene block polymer based adjuvants |
US4950645A (en) * | 1988-07-08 | 1990-08-21 | Immunotherapeutics, Inc. | Composition for macrophage activation |
-
1990
- 1990-04-13 US US07/509,338 patent/US5416070A/en not_active Expired - Fee Related
-
1991
- 1991-03-12 DK DK91908331.1T patent/DK0527803T3/da active
- 1991-03-12 WO PCT/US1991/001664 patent/WO1991016347A1/en active IP Right Grant
- 1991-03-12 ES ES91908331T patent/ES2071995T3/es not_active Expired - Lifetime
- 1991-03-12 EP EP91908331A patent/EP0527803B1/de not_active Expired - Lifetime
- 1991-03-12 DE DE69108392T patent/DE69108392T2/de not_active Expired - Fee Related
- 1991-03-12 JP JP91507981A patent/JPH05506657A/ja active Pending
- 1991-03-12 CA CA002080002A patent/CA2080002A1/en not_active Abandoned
- 1991-03-12 AT AT91908331T patent/ATE120207T1/de not_active IP Right Cessation
- 1991-04-03 IE IE110191A patent/IE74195B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5416070A (en) | 1995-05-16 |
DE69108392D1 (de) | 1995-04-27 |
ATE120207T1 (de) | 1995-04-15 |
EP0527803B1 (de) | 1995-03-22 |
ES2071995T3 (es) | 1995-07-01 |
CA2080002A1 (en) | 1991-10-14 |
JPH05506657A (ja) | 1993-09-30 |
WO1991016347A1 (en) | 1991-10-31 |
IE911101A1 (en) | 1991-10-23 |
IE74195B1 (en) | 1997-07-16 |
DK0527803T3 (da) | 1995-07-03 |
EP0527803A1 (de) | 1993-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI964681A0 (fi) | Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt | |
DK0758248T3 (da) | Formuleringer til faktor IX | |
IT1203515B (it) | Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono | |
ATE383169T1 (de) | Komponente und zusammensetzungen zur verabreichung von wirkstoffen | |
DE69531701D1 (de) | Sphingosome mit verbesserter arzneistoffabgage | |
DE69108392D1 (de) | Zusammensetzung zur aktivierung der makrophagen. | |
IL63122A (en) | Antihistaminic tricyclic alkylcarbamic and sulfamic acid esters,their preparation and pharmaceutical compositions containing them | |
ID17863A (id) | Komposisi-komposisi farmasi yang terdiri dari siklosporin | |
IL140710A0 (en) | Pulmonary delivery of active agents | |
EE9800223A (et) | Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine | |
CA2326761A1 (en) | Antitumor agent | |
IT8721253A0 (it) | Composizioni farmaceutiche e cosmetiche contenenti complessi di flavonolignani con fosfolipidi. | |
DE69806801D1 (de) | Galenische präparation zur prävention und behandlung von hepatokarzinomen | |
BR9711586A (pt) | Compostos e uso dos mesmo | |
BR9604950A (pt) | Composição farmacêutica contendo n-clorofenil carbamatos n-clorofeniltiocarbamatos e derivados de n-fosfonoglicina para inibir o crescimento de cânceres e vírus em mamíferos | |
ES2056180T3 (es) | Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina. | |
MX9100165A (es) | Composiciones para combatir tumores y procedimiento para su preparacion | |
DE68919225T2 (de) | Zusammensetzung für makrophag-aktivierung. | |
ATE157876T1 (de) | Wirkstofffreie liposomen zur behandlung von atherosklerose | |
IT8948430A0 (it) | Composti tripeptidici e loro uso farmaceutico come immuno-modulatori | |
EP0295695A3 (en) | New pyrazoline derivatives and agents for treating cerebnew pyrazoline derivatives and agents for treating cerebrovascular diseases containing the same as active ingredrovascular diseases containing the same as active ingredient ient | |
ES2128710T3 (es) | Liposomas que contienen proteinas encapsuladas, procedimiento para su produccion asi como las preparaciones farmaceuticas y cosmeticas que contienen estos liposomas. | |
IT8222911A0 (it) | Derivati della 1-metil-5-nitro-imidazolina e composizioni terapeutiche che li comprendono come principio attivo. | |
IT8167585A0 (it) | Composto chimico utilizzabile parti colarmente come agente farmaceutico antiulcera e procedimento per lasua fabbricazione | |
TR199901237T2 (xx) | Bir tienilsiklohegzilamin t�revinin tedavide yeni uygulamas�. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: ENDOREX CORP. (N.D.GES.D. STAATES DELAWARE), FARGO |
|
8339 | Ceased/non-payment of the annual fee |